Emerging biotherapies are enabling transition from traditional intravenous therapies to subcutaneous administration. These formulations may present delivery challenges, such as larger volumes and viscosities that require innovative, patient-friendly delivery system design.
In this webinar, our speakers will be focusing on two areas of interest:
- Impact of unique benchtop and preclinical methods
- In-depth overview of a clinical study on human response to an investigational wearable injector